Chemoinformaics analysis of 2,3,4-Trimethylhexane
| Molecular Weight | 128.259 | nRot | 3 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 0 |
| Exact Molecular Weight | 128.156 | nRing | 0 |
| Solubility: LogS | -6.168 | nHRing | 0 |
| Solubility: LogP | 6.169 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.3659 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.453 |
| Synth | 1.195 |
| Natural Product Likeliness | 0.222 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.471 |
| MDCK | 0.0000125 |
| BBB | 0.627 |
| PPB | 0.975653 |
| VDSS | 3.205 |
| FU | 0.0221269 |
| CYP1A2-inh | 0.91 |
| CYP1A2-sub | 0.323 |
| CYP2c19-inh | 0.583 |
| CYP2c19-sub | 0.328 |
| CYP2c9-inh | 0.303 |
| CYP2c9-sub | 0.92 |
| CYP2d6-inh | 0.085 |
| CYP2d6-sub | 0.097 |
| CYP3a4-inh | 0.151 |
| CYP3a4-sub | 0.083 |
| CL | 5.168 |
| T12 | 0.179 |
| hERG | 0.123 |
| Ames | 0.008 |
| ROA | 0.054 |
| SkinSen | 0.918 |
| Carcinogencity | 0.053 |
| EI | 0.968 |
| Respiratory | 0.585 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.934314 |